Emcure Pharma plans to launch $400-500 million IPO in 2024, hires Kotak.
Source: livemint.com The development revives the listing plans for Emcure Pharmaceuticals which it shelved as the Russia’s invasion of Ukraine disrupted global markets. Emcure Pharmaceuticals is planning to raise $400-500 million from initial public offering (IPO) in 2024, news agency Reuters quoted two sources on Monday. The development revives the listing plans for the pharmaceutical company which […]